This study was undertaken to study the efficiency of Adsflt-1 engineered human eutopic mesenchymal stem cells (MSCs) secreting anti-angiogenic sFlt-1 as a targeted cell-based therapy for endometriosis (EM). Eutopic MSCs were transduced with Adsflt-1/AdV0 viral vectors and were evaluated for expression and secretion of sFlt-1. EM was created in NOD/SCID mice using subcutaneous implantation techniques. Four doses of 106 MSC-Adsflt-1/MSC-AdV0 were administered to the model and therapeutic anti-angiogenic ability was analyzed by lesion size measurement, microvessel density, immunohistochemistry and real-time reverse transcriptase-PCR analysis. Approximately 86�f transduced MSCs expressed and secreted sFlt-1. MSC-Adsflt-1-treated animals exhibited significant reduction (52.8±1.8�in size of endometriotic lesions. We observed a 2.3-fold decrease in the number and a 10-fold decrease in the size of endometrial glands in MSC-Adsflt-1-treated animals. A two-fold decrease in stromal cell densities was also observed in MSC-Adsflt-1-treated animals compared with the MSC-AdV0 group. Specific positive immunostaining for MSC marker, CD146 and sFlt-1 in the lesion sites of the MSC-Adsflt-1 group suggests possible homing of transduced MSCs, their survival and secretion of sFlt-1 at the target sites. A marked reduction in size of microvessels and microvessel density within endometriotic lesions and surrounding host subcutaneous layers was observed in MSC-Adsflt-1 group along with significantly downregulated expression of transcripts for vascular endothelial growth factor, fetal liver kinase 1 and matrix metalloproteinases (2 and 9). Our findings indicate the efficacy of a novel eutopic MSC-Adsflt-1 therapy in EM study models. Evaluating long-term effects of genetically modified MSCs in vivo is essential in translating MSC-Adsflt-1 therapy to the clinics.
immunohistochemistry1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Immunohistochemistry  

MSC                           0.764407671845381^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/USB_mass_storage_device_class

real-time                     0.998430473841595^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Real-time_computing   

secretion                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Secretion             

sFlt-1                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Soluble_fms-like_tyrosine_kinase-1

implantation                  0.9995508033470353^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Implantation_(human_embryo)

transduced                    0.9999998820837915^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Signal_transduction   

sFlt-1                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Soluble_fms-like_tyrosine_kinase-1

sFlt-1                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Soluble_fms-like_tyrosine_kinase-1

transduced                    0.9999998820837915^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Signal_transduction   

lesion                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lesion                

vascular endothelial growth factor1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Vascular_endothelial_growth_factor

expression                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Gene_expression       

lesions                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lesion                

density                       0.999843344906473^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Density               

sFlt-1                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Soluble_fms-like_tyrosine_kinase-1

fold                          0.9976146985191859^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Protein_domain        

secretion                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Secretion             

lesion                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lesion                

viral vectors                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Viral_vector          

kinase                        0.9999998285709499^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Kinase                

matrix metalloproteinases     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Matrix_metalloproteinase

MSCs                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Mesenchymal_stem_cell 

transduced                    0.9999998820837915^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Signal_transduction   

anti-angiogenic               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Angiogenesis          

microvessel                   0.9999999999993179^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Microvessel           

mesenchymal stem cells (MSCs) 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Mesenchymal_stem_cell 

SCID mice                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Severe_combined_immunodeficiency_(non-human)

density                       0.999843344906473^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Density               

MSCs                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Mesenchymal_stem_cell 

liver                         0.9999999998785825^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Liver                 

genetically modified          0.9999556266600371^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Genetic_engineering   

MSCs                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Mesenchymal_stem_cell 

fold                          0.9976146985191859^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Protein_domain        

EM                            0.9999998251287405^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Endoplasmic_reticulum 

stromal cell                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Stromal_cell          

expression                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Gene_expression       

anti-angiogenic               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Angiogenesis          

microvessel                   0.9999999999993179^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Microvessel           

CD146                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/CD146                 

glands                        0.9999999980295797^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Lymph_node            

EM                            0.9999998251287405^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Endoplasmic_reticulum 

sFlt-1                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Soluble_fms-like_tyrosine_kinase-1

subcutaneous                  0.9709889761248766^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Subcutaneous_tissue   

1 group                       0.999999982472673^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/No._1_Group_RAF       

MSCs                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Mesenchymal_stem_cell 

endometrial                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Endometrium           

endometriosis                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Endometriosis         

EM                            0.9999998251287405^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Endoplasmic_reticulum 

efficacy                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Efficacy              

lesions                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lesion                

subcutaneous                  0.9709889761248766^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Subcutaneous_tissue   

immunostaining                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Immunohistochemistry  

1 group                       0.999999982472673^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/No._1_Group_RAF       

